-
Loading metrics
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study
- Stefania Gori,
- Alessandro Inno,
- Valentina Rossi,
- Monica Turazza,
- Elena Fiorio,
- Alessandra Fabi,
- Giancarlo Bisagni,
- Jennifer Foglietta,
- Daniele Santini,
- Ida Pavese
x
- Published: May 25, 2016
- https://doi.org/10.1371/journal.pone.0156221